Literature DB >> 15226402

The apical and basal environments of the retinal pigment epithelium regulate the maturation of tight junctions during development.

Christoph Rahner1, Masayuki Fukuhara, Shaomin Peng, Shota Kojima, Lawrence J Rizzolo.   

Abstract

A culture model has been established to study the gradual development of tight junctions during the embryogenesis of the chick retinal pigment epithelium. This study asks how closely the culture model reflects normal development and how the composition, structure and function of embryonic tight junctions are affected by the apical and basal environments. The study focused on the expression of claudins, the fine-structure of tight junctional strands and the transepithelial electrical resistance. Between embryonic days 7 and 14, patches of junctional strands gradually expanded and coalesced to form a continuous junction, in vivo. Although there was a corresponding increase in claudin expression, different claudins appeared at different times. In culture, the apical and basal environments acted synergistically to promote a continuous network of tight junctions with higher electrical resistance. Independently, pituitary extract or the secretory products of either embryonic fibroblasts or the retina promoted the formation of tight junctions. In combination, three effects were identified. With basally placed fibroblast conditioned medium, apical retinal medium increased transepithelial electrical resistance by affecting structure alone. With basally placed pituitary extract, apical retinal conditioned medium increased transepithelial electrical resistance by affecting structure and by modulating claudin expression in a manner that was consistent with development in vivo. Although embryonic day 7 and 14 cultures in retinal medium exhibited similar structure, the transepithelial electrical resistance of the embryonic day 14 cultures was higher. This higher transepithelial electrical resistance correlated with differences in claudin expression and localization. Therefore, this experimental model can isolate the effects of retinal secretions on structure and claudin expression, and can help us to determine how claudins affect function when structure is held constant.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15226402     DOI: 10.1242/jcs.01181

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  21 in total

1.  Claudin-19 and the barrier properties of the human retinal pigment epithelium.

Authors:  Shaomin Peng; Veena S Rao; Ron A Adelman; Lawrence J Rizzolo
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

2.  Renal, ocular, and neuromuscular involvements in patients with CLDN19 mutations.

Authors:  Stanislas Faguer; Dominique Chauveau; Pascal Cintas; Ivan Tack; Olivier Cointault; Lionel Rostaing; Rosa Vargas-Poussou; David Ribes
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

3.  Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue.

Authors:  Arvydas Maminishkis; Shan Chen; Stephen Jalickee; Tina Banzon; Guangpu Shi; Fei E Wang; Todd Ehalt; Jeffrey A Hammer; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

4.  HIV-1 gp120 Glycoprotein Interacting with Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN) Down-Regulates Tight Junction Proteins to Disrupt the Blood Retinal Barrier and Increase Its Permeability.

Authors:  Yi-Wen Qian; Chuan Li; Ai-Ping Jiang; Shengfang Ge; Ping Gu; Xianqun Fan; Tai-Sheng Li; Xia Jin; Jian-Hua Wang; Zhi-Liang Wang
Journal:  J Biol Chem       Date:  2016-09-07       Impact factor: 5.157

Review 5.  Directional Fluid Transport across Organ-Blood Barriers: Physiology and Cell Biology.

Authors:  Paulo S Caceres; Ignacio Benedicto; Guillermo L Lehmann; Enrique J Rodriguez-Boulan
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-03-01       Impact factor: 10.005

6.  Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement.

Authors:  Martin Konrad; Andre Schaller; Dominik Seelow; Amit V Pandey; Siegfried Waldegger; Annegret Lesslauer; Helga Vitzthum; Yoshiro Suzuki; John M Luk; Christian Becker; Karl P Schlingmann; Marcel Schmid; Juan Rodriguez-Soriano; Gema Ariceta; Francisco Cano; Ricardo Enriquez; Harald Juppner; Sevcan A Bakkaloglu; Matthias A Hediger; Sabina Gallati; Stephan C F Neuhauss; Peter Nurnberg; Stefanie Weber
Journal:  Am J Hum Genet       Date:  2006-09-19       Impact factor: 11.025

7.  Distribution and expression pattern of claudins 6, 7, and 9 in diffuse- and intestinal-type gastric adenocarcinomas.

Authors:  Erika Rendón-Huerta; Fortoul Teresa; Gorráez María Teresa; Garcia-Samper Xochitl; Alvarez-Fernández Georgina; Zavala-Zendejas Veronica; Luis Felipe Montaño
Journal:  J Gastrointest Cancer       Date:  2009-12-04

8.  Attainment of polarity promotes growth factor secretion by retinal pigment epithelial cells: relevance to age-related macular degeneration.

Authors:  Shozo Sonoda; Parameswaran G Sreekumar; Satoru Kase; Christine Spee; Stephen J Ryan; Ram Kannan; David R Hinton
Journal:  Aging (Albany NY)       Date:  2009-12-27       Impact factor: 5.682

9.  Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.

Authors:  Christopher J Mee; Helen J Harris; Michelle J Farquhar; Garrick Wilson; Gary Reynolds; Christopher Davis; Sven C D van IJzendoorn; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

10.  Developmental basis of nanophthalmos: MFRP Is required for both prenatal ocular growth and postnatal emmetropization.

Authors:  Olof H Sundin; Sharola Dharmaraj; Imran A Bhutto; Takuya Hasegawa; D Scott McLeod; Carol A Merges; Eduardo D Silval; Irene H Maumenee; Gerard A Lutty
Journal:  Ophthalmic Genet       Date:  2008-03       Impact factor: 1.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.